Idiopathic Ventricular Fibrillation "Le Syndrome d'Haïssaguerre" and the Fear of J Waves

Journal of the American College of Cardiology

Volumn 53, Issue 7, 2009, Pages 620-622

  Viskin, Sami ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

antiarrhythmic drugs; early repolarization; electrical storm; pacing; sudden cardiac death

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOPRENALINE; MEXILETINE; PROCAINAMIDE; QUINIDINE; VERAPAMIL;

ARRHYTHMOGENESIS; CLINICAL FEATURE; EDITORIAL; ELECTROCARDIOGRAM; HEALTH CARE SYSTEM; HEART VENTRICLE FIBRILLATION; HUMAN; LONG TERM CARE; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT QT SYNDROME;

ANTI-ARRHYTHMIA AGENTS; ELECTROCARDIOGRAPHY; HUMANS; ISOPROTERENOL; QUINIDINE; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION;

EID: 59649101858     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.11.011     Document Type: Editorial

References (31)

1. Viskin S., and Belhassen B. Idiopathic ventricular fibrillation. Am Heart J 120 (1990) 661-671
2. Belhassen B., Shapira I., Shoshani D., Paredes A., Miller H., and Laniado S. Idiopathic ventricular fibrillation: inducibility and beneficial effects of class I antiarrhythmic agents. Circulation 75 (1987) 809-816
3. Belhassen B., Viskin S., Fish R., Glick A., Setbon I., and Eldar M. Effects of electrophysiologic-guided therapy with class 1A antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol 10 (1999) 1301-1312
4. Viskin S., and Belhassen B. Idiopathic ventricular fibrillation. In: Gussak I., Antzelevitch C., Wilde A.A.M., Friedman P.A., Ackerman M.J., and Shen W.-K. (Eds). Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention (2008), Springer-Verlag London Ltd, London, UK 508-606
5. Viskin S., Lesh M., Eldar M., et al. Mode of onset of malignant ventricular arrhythmias in idiopathic ventricular fibrillation. J Cardiovasc Electrophysiol 8 (1997) 1115-1120
6. Haïssaguerre M., Shoda M., Jais P., et al. Mapping and ablation of idiopathic ventricular fibrillation. Circulation 106 (2002) 962-967
7. Haïssaguerre M., Derval N., Sacher F., et al. Sudden cardiac arrest associated with early repolarization. N Engl J Med 358 (2008) 2016-2023
8. Haïssaguerre M., Sacher F., Nogami A., et al. Characteristics of recurrent ventricular fibrillation associated with inferolateral early repolarization: role of drug therapy. J Am Coll Cardiol 53 (2009) 612-619
9. Nam G.B., Kim Y.H., and Antzelevitch C. Augmentation of J waves and electrical storms in patients with early repolarization. N Engl J Med 358 (2008) 2078-2079
10. Ohgo T., Okamura H., Noda T., et al. Acute and chronic management in patients with Brugada syndrome associated with electrical storm of ventricular fibrillation. Heart Rhythm 4 (2007) 695-700
11. Marquez M.F., Salica G., Hermosillo A.G., et al. Ionic basis of pharmacological therapy in Brugada syndrome. J Cardiovasc Electrophysiol 18 (2007) 234-240
12. Yan G.X., and Antzelevitch C. Cellular basis for the electrocardiographic J wave. Circulation 93 (1996) 372-379
13. Leenhardt A., Glaser E., Burguera M., Nurnberg M., Maison-Blanche P., and Coumel P. Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias. Circulation 89 (1994) 206-215
14. Shiga T., Shoda M., Matsuda N., et al. Electrophysiological characteristic of a patient exhibiting the short-coupled variant of torsade de pointes. J Electrocardiol 34 (2001) 271-275
15. Dock W. Transitory ventricular fibrillation as a cause of syncope and its prevention by quinidine sulfate. Am Heart J 4 (1929) 709-714
16. Belhassen B., Glick A., and Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation 110 (2004) 1731-1737
17. Belhassen B. A 25-year control of idiopathic ventricular fibrillation with electrophysiologic-guided antiarrhythmic drug therapy. Heart Rhythm 1 (2004) 352-354
18. Belhassen B., Glick A., and Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol (2009) In press.
19. Viskin S., Zeltser D., Ish-Shalom M., et al. Is idiopathic ventricular fibrillation a short QT syndrome?. Comparison of QT intervals of patients with idiopathic ventricular fibrillation and healthy controls. Heart Rhythm 1 (2004) 587-591
20. Milberg P., Tegelkamp R., Osada N., et al. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. J Cardiovasc Electrophysiol 18 (2007) 658-664
21. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12 (2001) 268-272
22. Viskin S., Antzelevitch C., Marquez M.F., and Belhassen B. Quinidine: a valuable medication joins the list of 'endangered species.'. Europace 9 (2007) 1105-1106
23. Dear Pharmacist Letter. Discontinuation of quinidine bisulphate. 2006. http://www.shpa.org.au/pdf/manuf_alerts/kinidin_may06.pdf Accessed December 20, 2008
24. Wilde A.A., and Langendijk P. Antiarrhythmic drugs, patients, and the pharmaceutical industry: value for patients, physicians, pharmacists or shareholders?. Neth Heart J 15 (2007) 127-128
25. Endres S., Mayuga K.A., de Cristofaro A., Taneja T., Goldberger J.J., and Kadish A.H. Age and gender difference in ST height at rest and after double autonomic blockade in normal adults. Ann Noninvasive Electrocardiol 11 (2006) 253-258
26. Rosso R., Kogan E., Belhassen B., et al. J-point elevation in survivors of primary ventricular fibrillation and matched control subjects incidence and clinical significance. J Am Coll Cardiol 52 (2008) 1231-1238
27. McGill Jr. H.C., Anselmo V.C., Buchanan J.M., and Sheridan P.J. The heart is a target organ for androgen. Science 207 (1980) 775-777
28. Sugao M., Fujiki A., Sakabe M., et al. New quantitative methods for evaluation of dynamic changes in QT interval on 24 hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome. Heart 92 (2006) 201-207
29. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2 (2005) 429-440
30. Viskin S., and Rogowski O. Asymptomatic Brugada syndrome: a cardiac ticking time-bomb?. Europace 9 (2007) 707-710
31. Paul M., Gerss J., Schulze-Bahr E., et al. Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data. Eur Heart J 28 (2007) 2126-2133